HRL
30
3
LOW
53
3
KHC
20
2
WEC
45
4
EQR
47
3
DHI
48
4
QRVO
4
2
BBY
45
3
HAS
37
4
EXPD
40
3
HCP
54
7
RF
54
3
DFS
60
4
NOC
45
13
MCO
67
3
MMM
30
2
GILD
62
2
MSI
63
2
LRCX
48
6
BLK
69
3
HRL
30
3
LOW
53
3
KHC
20
2
WEC
45
4
EQR
47
3
DHI
48
4
QRVO
4
2
BBY
45
3
HAS
37
4
EXPD
40
3
HCP
54
7
RF
54
3
DFS
60
4
NOC
45
13
MCO
67
3
MMM
30
2
GILD
62
2
MSI
63
2
LRCX
48
6
BLK
69
3
Financhill
Back

Axsome Therapeutics 10K Form

Buy
63

AXSM
Axsome Therapeutics

Last Price:
90.87
Seasonality Move:
48.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AXSM News And Ratings

See the #1 stock for the next 7 days that we like better than AXSM

AXSM Financial Statistics

Sales & Book Value

Annual Sales: $270.6M
Cash Flow: $-30.16M
Price / Cash Flow: 0
Annual Sales: $2.15
Price / Book: 41.65

Profitability

EPS (TTM): -6.51000
Net Income (TTM): $-308.55M
Gross Margin: $244.54M
Return on Equity: -156.44%
Return on Assets: -53.3%

Axsome Therapeutics Earnings Forecast

Key Axsome Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 4 years for AXSM is 90.37%.
  • The Selling, General & Administrative Expenses for AXSM have been equal to 119.41% of Gross Profit Margin.
  • The Research & Development expenses have been 36.20% of Revenue.
  • The Interest Expense is -2.70% of Operating Income.
  • The Net Earning history of AXSM is -88.41% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 2 years.

Axsome Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AXSM
CUSIP: 05464T
Website: axsome.com

Debt

Debt-to-Equity Ratio: 1.74
Current Ratio: 2.48
Quick Ratio: 2.34

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AXSM Technical Analysis vs Fundamental Analysis

Buy
63
Axsome Therapeutics (AXSM) is a Buy

Is Axsome Therapeutics a Buy or a Sell?